SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Metra M)
 

Sökning: WFRF:(Metra M) > (2004) > A description of th...

  • Cleland, J. G. (författare)

A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET)

  • Artikel/kapitelEngelska2004

Förlag, utgivningsår, omfång ...

  • 2004

Nummerbeteckningar

  • LIBRIS-ID:oai:gup.ub.gu.se/52305
  • https://gup.ub.gu.se/publication/52305URI
  • https://lup.lub.lu.se/record/898964URI
  • https://doi.org/10.1023/B:CARD.0000029032.46744.56DOI

Kompletterande språkuppgifter

  • Språk:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • BACKGROUND & AIMS: The COMET trial was a prospective, double-blind, randomised trial comparing carvedilol, a comprehensive adrenergic receptor antagonist, with metoprolol, a beta-1-selective agent in patients with heart failure and left ventricular systolic dysfunction. The trial showed a reduction in mortality with carvedilol that was consistent across subgroups. The purpose of this report is to describe in greater detail the heterogeneity of this population at baseline with particular reference to the impact of symptomatic severity, age and gender on patient characteristics. METHODS: A descriptive report using data entered in the COMET study data-base. RESULTS: The characteristics of the population studied were similar to those reported in previous trials of beta-blockers. Almost all patients were receiving diuretics and ACE inhibitors with few patients taking angiotensin receptor blockers. As expected, older patients had more co-morbidity. Older patients and women reported worse symptoms and poorer well-being despite similar ventricular dimensions and systolic dysfunction. NT-proBNP was higher in patients with more severe symptoms and older patients but not in women, although differences in NT-proBNP may have been confounded by differences in renal function. CONCLUSION: Age and gender, as well as the severity of cardiac dysfunction, appear to have an important effect on the severity of heart failure symptoms and patient 'well-being'. This could have important implications for the relationship between symptoms and prognosis and therefore the way in which patients are selected for clinical trials and the goals of treatment. This will be the subject of further analyses.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Goode, K. (författare)
  • Erhardt, Leif RWLund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups(Swepub:lu)medf-ler (författare)
  • Remme, W. J. (författare)
  • Charlesworth, A. (författare)
  • Poole-Wilson, P. A. (författare)
  • Di Lenarda, A. (författare)
  • Hanrath, P. (författare)
  • Komajda, M. (författare)
  • Metra, M. (författare)
  • Swedberg, Karl,1944Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute(Swepub:gu)xsweka (författare)
  • Torp-Pedersen, C. (författare)
  • Trop-Pedersen, C (författare)
  • Internmedicin - epidemiologiForskargrupper vid Lunds universitet (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy18:2, s. 139-520920-3206

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy